(Q40622075)

22 September 2017

1 reference

title

Antiparkinsonian drugs in the treatment of neuroleptic-induced extrapyramidal symptoms (English)

1 reference

22 September 2017

author name string

Bezchlibnyk-Butler KZ

series ordinal

1

1 reference

22 September 2017

Remington GJ

series ordinal

2

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 March 1994

1 reference

Canadian Journal of Psychiatry

22 September 2017

published in

1 reference

22 September 2017

volume

39

1 reference

22 September 2017

issue

2

1 reference

22 September 2017

page(s)

74-84

1 reference

Antidepressants and the Muscarinic Acetylcholine Receptor

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F070674379403900203

Muscarinic receptor subclassification and G-proteins: significance for lithium action in affective disorders and for the treatment of the extrapyramidal side effects of neuroleptics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379403900203

A controlled trial of anti-Parkinson drugs in drug-induced Parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379403900203

A Double-Blind Study of Amantadine Hydrochloride versus Benztropine Mesylate in Drug-Induced Parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379403900203

A Controlled Trial of Amantadine in Drug-Induced Extrapyramidal Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379403900203

Clinical characteristics of akathisia. A systematic investigation of acute psychiatric inpatient admissions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379403900203

Intravenous diazepam in the treatment of neuroleptic-induced acute dystonia and akathisia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379403900203

Sodium valproate and biperiden in neuroleptic-induced akathisia, parkinsonism and hyperkinesia. A double-blind cross-over study with placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379403900203

Efficacy of anticholinergic prophylaxis for neuroleptic-induced acute dystonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379403900203

Differential memory function with dopaminergic versus anticholinergic treatment of drug-induced extrapyramidal symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379403900203

Anticholinergic Effects on Memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379403900203

Effects of amantadine and trihexyphenidyl on memory in elderly normal volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379403900203

Anti-cholinergic drugs and memory: the effects of benzhexol on memory in a group of geriatric patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379403900203

Comment on the WHO consensus statement: Prophylactic use of anticholinergics in patients on long-term neuroleptic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379403900203

Type I tardive dyskinesia induced by anticholinergic drugs, dopamine agonists and neuroleptics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379403900203

Plasma levels of perphenazine and its major metabolites during simultaneous treatment with anticholinergic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379403900203

Effect of anticholinergic medication on positive and negative symptoms in medication-free schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379403900203

Low plasma iron status and akathisia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379403900203

Low serum iron in patients with neuroleptic-induced akathisia and dystonia under antipsychotic drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379403900203

Clinical pharmacokinetics of anti-parkinsonian drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379403900203

Antischizophrenic drugs and brain cholinergic receptors. Affinity for muscarinic sites predicts extrapyramidal effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379403900203

10.1177/070674379403900203

21 January 2018

Identifiers

DOI

1 reference

22 September 2017

1 reference